GO
Loading...

St. Jude Medical Inc

More

  • Final Glance: Medical Devices companies Monday, 18 Aug 2014 | 6:02 PM ET

    Allergan fell $2.65 or 1.7 percent, to $155.61. Baxter International Inc. rose$. 80 or 1.1 percent, to $75.21. Boston Scientific Corp. rose$. 18 or 1.4 percent, to $12.64.

  • Early Glance: Medical Devices companies Monday, 18 Aug 2014 | 10:29 AM ET

    Allergan fell $1.26 or. 8 percent, to $157.00. Baxter International Inc. rose$. 81 or 1.1 percent, to $75.22. Boston Scientific Corp. rose$. 14 or 1.1 percent, to $12.60.

  • UPDATE 2-St. Jude not keen to join inversion deal craze Wednesday, 16 Jul 2014 | 3:39 PM ET

    In the most recent such deal in the medical device sector, Medtronic Inc last month agreed to buy Covidien for $43 billion. The move will allow Medtronic to re-domicile to Ireland to take advantage of low corporate tax rates and to access cash overseas without having to pay high repatriation costs.

  • Will earnings tell the story markets need to hear? Sunday, 13 Jul 2014 | 6:21 PM ET
    Traders work the floor of the New York Stock Exchange before the closing bell in New York.

    Quarterly earnings growth and clues from companies' commentaries will tell whether there really will be a bounce back in growth in the second half.

  • July 2- St. Jude Medical Inc said the U.S. Food and Drug Administration notified the company that issues regarding its Sylmar, California- based manufacturing plant have been resolved. The FDA last year had warned St.

  • July 2- St. Jude Medical Inc said the U.S. Food and Drug Administration notified the company that issues regarding its Sylmar, California- based manufacturing plant have been resolved. The FDA last year had warned St. Jude of serious violations at the plant where the Durata and Riata leads for implantable defibrillators are made.

  • June 16- Medtronic Inc's $43 billion deal for Dublin- based Covidien Plc should accelerate already intense efforts by medical device rivals to seek merger partners, industry analysts and bankers said on Monday.

  • Midday movers: Medtronic, Netflix, Tesla Motors & More Monday, 16 Jun 2014 | 12:12 PM ET
    NYSE EuroNext flag hangs outside the NYSE.

    Some of Monday's midday movers:

  • Medtronic’s $43B Covidien deal: More to come? Monday, 16 Jun 2014 | 9:26 AM ET
    Medtronic Chairman and Chief Executive Omar Ishrak.

    Medtronic's $43 billion Covidien deal may signal future medical-device company mergers.

  • *Schroders urges AstraZeneca to restart talks with Pfizer. LONDON, May 20- Schroders, AstraZeneca's 12th- biggest shareholder, urged the drugmaker to restart takeover talks with Pfizer as rival Fidelity Worldwide Investment, ranking 18th, backed the British company's stance.

  • *Schroders urges AstraZeneca to restart talks with Pfizer. LONDON, May 20- Schroders, AstraZeneca's 12th- biggest shareholder, urged the drugmaker to restart takeover talks with Pfizer as rival Fidelity, ranking 18th, backed the British company's stance.

  • LONDON, May 20- AstraZeneca shareholder Schroders urged the company to restart takeover talks with Pfizer, adding its voice to criticism of the British drugmaker's rejection of the U.S. firm's 70 billion pound bid. Schroders is AstraZeneca's twelfth-largest shareholder with a 2 percent stake.

  • Boston Scientific subpoenaed over heart device Friday, 9 May 2014 | 6:25 AM ET
    U.S. Department of Health and Human Services building, Washington, DC.

    Boston Scientific received a subpoena this week from the Department of Health and Human Services seeking information about its defibrillators.

  • Boston Scientific gets subpoena over defibrillators Thursday, 8 May 2014 | 11:37 PM ET

    May 8- Medical device maker Boston Scientific Corp said it received a subpoena this week from the Department of Health and Human Services seeking information about the performance of some of its implanted defibrillators. Boston Scientific, which competes with Medtronic Inc and St. Jude Medical Inc in selling ICDs, said it is cooperating with the request.

  • NEW YORK, May 1- Invesco Ltd, which oversees the PowerShares line of exchange-traded funds, said on Thursday its first-quarter profit fell 15.5 percent, pressured by an increase in operating expenses that included a fine from British regulators. The fine reduced Invesco's quarterly diluted earnings per share by 7 cents, the company said.

  • April 29- Boston Scientific Corp's quarterly revenue fell short of expectations due to lower sales of its implantable defibrillators and pacemakers, sending its shares down as much as 6 percent. Boston Scientific said it expected subcutaneous ICD sales of over $75 million in 2014..

  • Early movers: BAC, PNC, YHOO, GM & more Wednesday, 16 Apr 2014 | 7:46 AM ET
    Traders on the floor of the New York Stock Exchange on April 11, 2014

    Some of the names on the move ahead of the open.

  • Wall Street analysts had estimated a potential market of $3 billion for the devices made by Medtronic Inc, Boston Scientific Corp and St Jude Medical Inc. But failure of the high-stakes clinical trial set off a heated debate between doctors who believe the approach is worth saving and those who say results show it provides no clear benefit.

  • Lightning Round: Vodafone, Sirius XM & More Tuesday, 18 Mar 2014 | 6:38 PM ET

    It's time for the Lightning Round. Cramer makes the call on viewer favorites.

  • Midday movers: Apple, Darden Restaurants & More Monday, 10 Feb 2014 | 12:22 PM ET

    Some of Monday's midday movers: